ACRS
Aclaris TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
ACRS vs peer average
72/100
ACRS vs. peer average (A vs. B)
Grade spread
A 4 · B 3 · D 1 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
CRMD is the first available peer comparator.
A same-sector company with more operating ballast, useful as a check on how the market rewards clinical progress versus commercial durability.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ACRS
Aclaris Therapeutics
CRMD
CorMedix
Grade
A
A
Momentum
88
65
Value
41
68
Sentiment
68
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CRMD
ACRS / CRMD
Grade Position
Above peers
ACRS vs. peer average (A vs. B)
72/100
Momentum
88
ACRSValue
41
CRMDSentiment
68
CRMDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ACRS
CRMD is the first peer returned for this comparison set.